The company’s IPO comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors
Drug maker Mankind Pharma on Friday filed its draft red herring prospectus (DRHP) with market regulator Sebi for an initial public offering (IPO). The size of the offer is expected to be Rs 5,500 crore.
The company’s IPO comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.
The offer for sale comprises up to 1 crore shares by promoter Juneja family, up to 2 crore shares by Capital International, up to 99.65 lakh by Beige, and up to 50,000 equity shares by Link Investment Trust.
In the current arrangement, The ChrysCapital-backed consortium of GIC of Singapore and CPP Investments owns 10 per cent of Mankind, while Capital International owns another 11 per cent stake.
The company has hired JM Morgan, Citi, Jefferies, Axis, IIFL, and Kotak as investment bankers.